Literature DB >> 24598141

Transcriptional regulation of apolipoprotein A-IV by the transcription factor CREBH.

Xu Xu1, Jong-Gil Park, Jae-Seon So, Kyu Yeon Hur, Ann-Hwee Lee.   

Abstract

cAMP responsive element-binding protein H (CREBH) is an endoplasmic reticulum (ER) anchored transcription factor that is highly expressed in the liver and small intestine and implicated in nutrient metabolism and proinflammatory response. ApoA-IV is a glycoprotein secreted primarily by the intestine and to a lesser degree by the liver. ApoA-IV expression is suppressed in CREBH-deficient mice and strongly induced by enforced expression of the constitutively active form of CREBH, indicating that CREBH is the major transcription factor regulating Apoa4 gene expression. Here, we show that CREBH directly controls Apoa4 expression through two tandem CREBH binding sites (5'-CCACGTTG-3') located on the promoter, which are conserved between human and mouse. Chromatin immunoprecipitation and electrophoretic mobility-shift assays demonstrated specific association of CREBH with the CREBH binding sites. We also demonstrated that a substantial amount of CREBH protein was basally processed to the active nuclear form in normal mouse liver, which was further increased in steatosis induced by high-fat diet or fasting, increasing apoA-IV expression. However, we failed to find significant activation of CREBH in response to ER stress, arguing against the critical role of CREBH in ER stress response.

Entities:  

Keywords:  ER stress; cAMP responsive element-binding protein H; hepatic steatosis

Mesh:

Substances:

Year:  2014        PMID: 24598141      PMCID: PMC3995463          DOI: 10.1194/jlr.M045104

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  50 in total

1.  N-linked glycosylation is required for optimal proteolytic activation of membrane-bound transcription factor CREB-H.

Authors:  Chi-Ping Chan; To-Yuen Mak; King-Tung Chin; Irene Oi-Lin Ng; Dong-Yan Jin
Journal:  J Cell Sci       Date:  2010-03-31       Impact factor: 5.285

2.  Pretreatment with CO-releasing molecules suppresses hepcidin expression during inflammation and endoplasmic reticulum stress through inhibition of the STAT3 and CREBH pathways.

Authors:  Da-Yong Shin; Jihwa Chung; Yeonsoo Joe; Hyun-Ock Pae; Ki Churl Chang; Gyeong Jae Cho; Stefan W Ryter; Hun-Taeg Chung
Journal:  Blood       Date:  2012-01-19       Impact factor: 22.113

3.  Apolipoprotein A-IV improves glucose homeostasis by enhancing insulin secretion.

Authors:  Fei Wang; Alison B Kohan; Tammy L Kindel; Kathryn L Corbin; Craig S Nunemaker; Silvana Obici; Stephen C Woods; W Sean Davidson; Patrick Tso
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-22       Impact factor: 11.205

Review 4.  Regulation of cholesterol and fatty acid synthesis.

Authors:  Jin Ye; Russell A DeBose-Boyd
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

5.  Transcriptional profiling reveals divergent roles of PPARalpha and PPARbeta/delta in regulation of gene expression in mouse liver.

Authors:  Linda M Sanderson; Mark V Boekschoten; Beatrice Desvergne; Michael Müller; Sander Kersten
Journal:  Physiol Genomics       Date:  2009-12-15       Impact factor: 3.107

6.  The liver-enriched transcription factor CREBH is nutritionally regulated and activated by fatty acids and PPARalpha.

Authors:  Hirosuke Danno; Kiyo-aki Ishii; Yoshimi Nakagawa; Motoki Mikami; Takashi Yamamoto; Sachiko Yabe; Mika Furusawa; Shin Kumadaki; Kazuhisa Watanabe; Hidehisa Shimizu; Takashi Matsuzaka; Kazuto Kobayashi; Akimitsu Takahashi; Shigeru Yatoh; Hiroaki Suzuki; Nobuhiro Yamada; Hitoshi Shimano
Journal:  Biochem Biophys Res Commun       Date:  2009-12-16       Impact factor: 3.575

7.  Estrogen-related receptor alpha (ERRalpha) is a transcriptional regulator of apolipoprotein A-IV and controls lipid handling in the intestine.

Authors:  Julie C Carrier; Geneviève Deblois; Céline Champigny; Emile Levy; Vincent Giguère
Journal:  J Biol Chem       Date:  2004-10-04       Impact factor: 5.157

8.  Protection against atherogenesis in mice mediated by human apolipoprotein A-IV.

Authors:  N Duverger; G Tremp; J M Caillaud; F Emmanuel; G Castro; J C Fruchart; A Steinmetz; P Denèfle
Journal:  Science       Date:  1996-08-16       Impact factor: 47.728

9.  Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV.

Authors:  I J Goldberg; C A Scheraldi; L K Yacoub; U Saxena; C L Bisgaier
Journal:  J Biol Chem       Date:  1990-03-15       Impact factor: 5.157

10.  Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion.

Authors:  Melissa A VerHague; Dongmei Cheng; Richard B Weinberg; Gregory S Shelness
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-09-12       Impact factor: 8.311

View more
  25 in total

1.  Transcriptional activation of Fsp27 by the liver-enriched transcription factor CREBH promotes lipid droplet growth and hepatic steatosis.

Authors:  Xu Xu; Jong-Gil Park; Jae-Seon So; Ann-Hwee Lee
Journal:  Hepatology       Date:  2015-01-28       Impact factor: 17.425

2.  Loss of Transcription Factor CREBH Accelerates Diet-Induced Atherosclerosis in Ldlr-/- Mice.

Authors:  Jong-Gil Park; Xu Xu; Sungyun Cho; Ann-Hwee Lee
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-14       Impact factor: 8.311

3.  CREBH normalizes dyslipidemia and halts atherosclerosis in diabetes by decreasing circulating remnant lipoproteins.

Authors:  Masami Shimizu-Albergine; Debapriya Basu; Jenny E Kanter; Farah Kramer; Vishal Kothari; Shelley Barnhart; Carissa Thornock; Adam E Mullick; Noemie Clouet-Foraison; Tomas Vaisar; Jay W Heinecke; Robert A Hegele; Ira J Goldberg; Karin E Bornfeldt
Journal:  J Clin Invest       Date:  2021-11-15       Impact factor: 14.808

Review 4.  Apolipoprotein A-IV: a protein intimately involved in metabolism.

Authors:  Fei Wang; Alison B Kohan; Chun-Min Lo; Min Liu; Philip Howles; Patrick Tso
Journal:  J Lipid Res       Date:  2015-02-01       Impact factor: 5.922

5.  Very Low Density Lipoprotein Assembly Is Required for cAMP-responsive Element-binding Protein H Processing and Hepatic Apolipoprotein A-IV Expression.

Authors:  Dongmei Cheng; Xu Xu; Trang Simon; Elena Boudyguina; Zhiyong Deng; Melissa VerHague; Ann-Hwee Lee; Gregory S Shelness; Richard B Weinberg; John S Parks
Journal:  J Biol Chem       Date:  2016-09-21       Impact factor: 5.157

Review 6.  Circadian regulators of intestinal lipid absorption.

Authors:  M Mahmood Hussain; Xiaoyue Pan
Journal:  J Lipid Res       Date:  2014-07-23       Impact factor: 5.922

Review 7.  Transcription factors activated through RIP (regulated intramembrane proteolysis) and RAT (regulated alternative translocation).

Authors:  Jin Ye
Journal:  J Biol Chem       Date:  2020-06-02       Impact factor: 5.157

8.  Dietary protein restriction reduces circulating VLDL triglyceride levels via CREBH-APOA5-dependent and -independent mechanisms.

Authors:  J Humberto Treviño-Villarreal; Justin S Reynolds; Alexander Bartelt; P Kent Langston; Michael R MacArthur; Alessandro Arduini; Valeria Tosti; Nicola Veronese; Beatrice Bertozzi; Lear E Brace; Pedro Mejia; Kaspar Trocha; Gustavo S Kajitani; Alban Longchamp; Eylul Harputlugil; Rose Gathungu; Susan S Bird; Arnold D Bullock; Robert S Figenshau; Gerald L Andriole; Andrew Thompson; Jöerg Heeren; C Keith Ozaki; Bruce S Kristal; Luigi Fontana; James R Mitchell
Journal:  JCI Insight       Date:  2018-11-02

9.  Hepatic Sel1L-Hrd1 ER-associated degradation (ERAD) manages FGF21 levels and systemic metabolism via CREBH.

Authors:  Asmita Bhattacharya; Shengyi Sun; Heting Wang; Ming Liu; Qiaoming Long; Lei Yin; Sander Kersten; Kezhong Zhang; Ling Qi
Journal:  EMBO J       Date:  2018-11-02       Impact factor: 11.598

10.  Secrets of secretion-How studies of the Drosophila salivary gland have informed our understanding of the cellular networks underlying secretory organ form and function.

Authors:  Rajprasad Loganathan; Ji Hoon Kim; Michael B Wells; Deborah J Andrew
Journal:  Curr Top Dev Biol       Date:  2020-11-19       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.